Sofinnova Partners SAS reported a 5.4% stake in Quince Therapeutics QNCX · 2,397,711 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.4%
Last report: First report
Shares held: 2,397,711 sh
Class: Common Stock, par value $0.001 per share
Stock: Quince Therapeutics QNCX
Holder: Sofinnova Partners SAS
Event date: 24/12/31
Filed: 25/02/14

First 5%+ report · 5.4% stake

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

Sofinnova Partners SAS's other 5% stake reports

Sofinnova Partners SAS
5% stakeQuince Therapeutics
5% stake
Quince Therapeutics
QNCX
2.7% stake
1,197,711 sh
2.7% stake
Filed 25/04/30